Director Network Supply Planning

Responsibilities

• Lead the Network Supply Planning Team for the Alexion Rare Disease Business Unit, ensuring activities support patient needs and regulatory requirements.
• Own the end-to-end network supply planning strategy and execution across a 0–3-year horizon to ensure reliable product supply and optimal inventory levels.
• Lead the global Sales & Operations Execution (S&OE) process to drive alignment between demand, supply, capacity, and inventory.
• Manage supply risk and disruption mitigation, identifying vulnerabilities early and developing proactive continuity plans.
• Establish and embed best-in-class supply planning standards, governance, and performance metrics (KPIs) across the global network.
• Partner with senior cross-functional leaders in regulatory, quality, finance, and manufacturing to ensure aligned planning and execution.
• Drive continuous improvement and digitalization of supply planning processes to improve accuracy and responsiveness.

Requirements

• 10+ years of experience in biopharmaceutical operations, global supply chain, or supply planning within a complex, regulated environment.
• Proven leadership experience managing global or matrixed teams in supply planning or network operations.
• Deep understanding of end-to-end product supply, including manufacturing, external supply, distribution, and market delivery.
• Strong expertise in supply risk management, continuity planning, and operational risk assessment.
• Bachelor’s degree in science, engineering, supply chain, operations, or business.
• Working knowledge of GMP, quality systems, and regulatory requirements.

Preferred Qualifications

• Advanced degree such as an MBA or MS.
• Experience with digital planning and project management tools (e.g., Smartsheet).
• Proven track record in launch readiness and product lifecycle planning.

About the Company

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. Through its Alexion Rare Disease Business Unit, the company is dedicated to delivering life-changing medicines to patients with rare diseases worldwide.